KING OF PRUSSIA, PA, April 1 /PRNewswire-FirstCall/ - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has hired Teresa F. Winslow as Senior Vice President -- Global Business Development and James Miskel as Vice President -- Strategy and Corporate Development. To improve the business’ growth profile, Ms. Winslow will direct global business development efforts and Mr. Miskel will focus on strategic partnerships.
“I’m delighted to add these two experienced leaders to our senior management team,” said MDS Pharma Services President David Spaight. “Their skills and knowledge will allow us to seize emerging opportunities to accelerate the growth of our business.”
Ms. Winslow is an experienced executive leader of business development in the healthcare industry. She was previously President -- Dendrite Americas and Senior Vice President -- Dendrite International, a leading supplier of sales force and marketing effectiveness solutions for the pharmaceutical industry. Ms. Winslow oversaw all operations, sales and marketing functions and led double-digit growth of the company’s largest division. A pharmacist by training, she earned a BS in Pharmacy from the University of the Sciences in Philadelphia.
Mr. Miskel joined MDS from Wyeth Pharmaceuticals, where he was Assistant Vice President for Business Planning & Strategy. He spent much of his career with McKinsey & Company, leading growth strategy, operational improvement, and acquisition work in the Americas and Europe for leading pharmaceutical and medical device companies. He holds an MBA from the Wharton School and an MA in International Studies from the Lauder Institute, both of the University of Pennsylvania, and originally trained as an aeronautical engineer, earning MS and BS degrees from the Massachusetts Institute of Technology.
About MDS Pharma Services
MDS Pharma Services is committed to delivering quality service on-time. We offer a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at www.mdsps.com.
MDS Pharma Services is a business unit of MDS Inc. , a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly skilled people in 29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.
CONTACT: For Investors: Kim Lee, (416) 675-6777 ext. 32606,
kim.lee@mdsinc.com; For Media: Charlene McGrady, (610) 239-7900 ext. 231,
charlene.mcgrady@mdsinc.com
